The note is the current scenario (Base). Download PDF renders this page on the server, fonts and colours exact; Print uses the browser.
Model Note · ARISTO BIO T AND LIFESC L · 31 October 2026Page 1 of 2
Model Note
Prepared by the reader · not a MarketPing document
ARISTO BIO T AND LIFESC L Discounted cash flow · base FY26
ARISTO BIO T AND LIFESC L
Value per share, this model₹59
CMP, 30 Oct 2026₹86.00
Difference(31.5)%
Growth the CMP implies—
This note states the assumptions and the arithmetic of one model of ARISTO BIO T AND LIFESC L, built on its filed FY26 standalone statements. The value is the outcome of the assumptions below and nothing else; it is not a fair value, a target or a recommendation.
Assumptions
Input
This model
Filed reference
Revenue growth, 5 years
14.5% a year
FY26 14.3% · 5-yr CAGR —%
EBITDA margin
3.6%
FY26 3.6% · 5-yr average 2.9%
Depreciation · capex, % of revenue
0% · 0.7%, fading to 1.2× depreciation
FY26 0.0% · 0.7%
Working capital, % of added revenue · tax
17.4% · 25.9%
63 working-capital days · effective 25.9%
Discount rate
11.00%
1-yr beta 0.39
After FY31
5% flat · mid-year discounting
—
Net debt · non-controlling interest · non-operating investments
₹(3) · ₹0 · ₹0 cr
FY26 net debt ₹(3) cr
Shares
0.68 crore
0.68 crore today
Source: SEBI results XBRL as filed with BSE/NSE, exchange prices; the reader's assumptions.
Projected cash flow to the firm
₹ crore
FY26
FY27
FY28
FY29
FY30
FY31
Revenue
364
416
477
546
625
716
growth %
14.3
14.5
14.5
14.5
14.5
14.5
EBITDA
13
15
17
20
23
26
Depreciation
0
0
0
0
0
0
NOPAT
10
11
13
15
17
19
less capex
(3)
(3)
(3)
(2)
(1)
0
less working-capital build
—
(9)
(11)
(12)
(14)
(16)
Free cash flow to firm
—
(1)
(0)
1
2
3
Present value
(1)
(0)
0
1
2
Source: the model; base year as filed.
Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in
Model Note · ARISTO BIO T AND LIFESC L · 31 October 2026Page 2 of 2
From enterprise to equity
PV of the 5 explicit years
3
PV of the terminal value (93% of EV)
35
Enterprise value
37
less net debt
3
less non-controlling interest
0
add non-operating investments
0
Equity value
40
÷ 0.68 crore shares
₹59
Source: the model.
Sensitivity, ₹ per share
WACC ↓ · terminal growth →
4.0%
4.5%
5.0%
5.5%
6.0%
10.0%
61
66
72
79
89
10.5%
56
60
65
71
78
11.0%
51
55
59
64
70
11.5%
47
50
54
58
63
12.0%
44
47
50
53
57
Source: the model; n/a where terminal growth reaches the discount rate.
Statement
This note is the reader's own model over publicly filed information: SEBI results XBRL filed with BSE and NSE and exchange price data, assembled by MarketPing software; every assumption above is the reader's. It contains no research recommendation, no price target and no opinion by MarketPing on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Historical per-share figures are on the current share count. Where a figure is unavailable the table shows a dash rather than an estimate. Nothing here constitutes investment advice, an offer or a solicitation.
Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in
